<SEC-DOCUMENT>0001558370-21-001475.txt : 20210223
<SEC-HEADER>0001558370-21-001475.hdr.sgml : 20210223
<ACCEPTANCE-DATETIME>20210223163043
ACCESSION NUMBER:		0001558370-21-001475
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210219
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210223
DATE AS OF CHANGE:		20210223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GLYCOMIMETICS INC
		CENTRAL INDEX KEY:			0001253689
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36177
		FILM NUMBER:		21665986

	BUSINESS ADDRESS:	
		STREET 1:		9708 MEDICAL CENTER DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		240-243-1201

	MAIL ADDRESS:	
		STREET 1:		9708 MEDICAL CENTER DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>glyc-20210219x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 9.6.7713.40453 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 2/23/2021 9:30:22 PM -->
      <!-- iXBRL Library version: 1.0.7713.40461 -->
      <!-- iXBRL Service Job ID: 6f1cd6e6-32ba-4ed0-808e-3be2ccdc90a0 -->

  <html xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:glyc="http://www.glycomimetics.com/20210219" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" name="dei:EntityCentralIndexKey" id="Tc_v3CzH-7TXUCz2qpW6VV_eA_2_1">0001253689</ix:nonNumeric><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" name="dei:AmendmentFlag" id="Tc_owTmJ8QYl0KQeDEf_MZpSg_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="glyc-20210219.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_2_19_2021_To_2_19_2021_JWL2LJtHS0WjDuQHPj3dKA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001253689</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-19</xbrli:startDate><xbrli:endDate>2021-02-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001253689</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-07</xbrli:startDate><xbrli:endDate>2020-10-07</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:9.41%;padding-right:9.41%;position:relative;"><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;border-top:9pt double #000000;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_a8ff4002_8156_48fa_877e_0f8644b6b8da"></a><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;letter-spacing:-0.1pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:0pt;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:14pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Washington, DC 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FORM </b><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" name="dei:DocumentType" id="Narr_O2fhNwlCm02TKG-_Z3oEqQ"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pursuant to Section 13 or 15(d) of</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">The Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:9pt;font-weight:bold;">Date of Report (Date of earliest event reported): </b><ix:nonNumeric contextRef="Duration_2_19_2021_To_2_19_2021_JWL2LJtHS0WjDuQHPj3dKA" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_G8MMoVw3P0SQGDmUDTCtZw"><b style="font-size:9pt;font-weight:bold;">February 19, 2021</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" name="dei:EntityRegistrantName" id="Narr_K8Y4vfFOZUa6tggmiN6Kcw"><b style="font-weight:bold;">GlycoMimetics, Inc.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Exact name of registrant as specified in its charter)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><a id="_e1f4de58_61bd_4709_b865_8049cd6378dd"></a><a id="Tc_0xBZPINmlEOtLpWph3-u6A_2_0"></a><a id="Tc_-e-d-NFNvEuHBO7o5PYvNw_2_2"></a><a id="Tc_6r89EUy7VUml-Qssd0UUrA_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:29.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:3.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:31.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:32.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:29.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_ljzyWs_qQEK_imUTDSwU1Q_1_0"><b style="font-size:9pt;font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:3.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" name="dei:EntityFileNumber" id="Tc_q2NpS5wpQkS98fPEVzGtzA_1_2"><b style="font-size:9pt;font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">001-36177</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" name="dei:EntityTaxIdentificationNumber" id="Tc_weuuiY1AAUiot3H7ieGi4g_1_4"><b style="font-size:9pt;font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">06-1686563</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:29.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(State or other jurisdiction of incorporation)</p></td><td style="vertical-align:bottom;width:3.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Commission File Number)</p></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(IRS Employer<br />Identification No.)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" name="dei:EntityAddressAddressLine1" id="Narr_PvFooujLY02ONIoqtwGnaw"><b style="font-size:9pt;font-weight:bold;">9708 Medical Center Drive</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" name="dei:EntityAddressCityOrTown" id="Narr_VYSaZt2q9UmoFUfDLyRUGA"><b style="font-size:9pt;font-weight:bold;">Rockville</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" name="dei:EntityAddressStateOrProvince" id="Narr_wDIkgHNEZkC_FJpEaofRfg"><b style="font-size:9pt;font-weight:bold;">MD</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" name="dei:EntityAddressPostalZipCode" id="Narr_0HfjVvSGeE2nkMsuQWtU8g"><b style="font-size:9pt;font-weight:bold;">20850</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Address of principal executive offices, including zip code)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:9pt;font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" name="dei:CityAreaCode" id="Narr_K_fp6oeFY02JYDsRzVd5yw"><b style="font-size:9pt;font-weight:bold;">240</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" name="dei:LocalPhoneNumber" id="Narr_i1lVk4vFIEa_WPOHiGFUVw"><b style="font-size:9pt;font-weight:bold;">243-1201</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Registrant&#8217;s telephone number, including area code)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">N/A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Former name or former address, if changed since last report)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.25pt;text-indent:-14.25pt;margin:5pt 0pt 5pt 0pt;"><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_Cf69zpq-uE2G8pmzhiJuoQ"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;"> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.25pt;text-indent:-14.25pt;margin:5pt 0pt 5pt 0pt;"><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_X0A8DDt4GkqAdemOH9cptA"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-family:'Segoe UI Symbol';font-size:9pt;"> </span><span style="font-size:9pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.25pt;text-indent:-14.25pt;margin:5pt 0pt 5pt 0pt;"><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_xDTDxYtXJE67sM0vLKObnw"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-family:'Segoe UI Symbol';font-size:9pt;"> </span><span style="font-size:9pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;padding-left:14.25pt;text-indent:-14.25pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_YYZ-3Aj5ikq14B-qi3H97A"><span style="font-family:'Segoe UI Symbol';font-size:9pt;letter-spacing:0pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;letter-spacing:0pt;"> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;padding-left:14.25pt;text-indent:-14.25pt;margin:0pt;"><span style="font-size:9pt;letter-spacing:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><a id="_815aaab8_f3ad_460f_b7c2_43bd0f552b4c"></a><div style="margin-left:0pt;"><a id="Tc_YhYKAtEcvkWw_XJD2BCozw_1_0"></a><a id="Tc_JI0Hwn4z4kutrSmGq1YABg_1_1"></a><a id="Tc_XoHYZxTPUU2tg1WVfDeHCw_1_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;width:97.58%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:22.29%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:44.35%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:33.34%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:5pt 0pt 5pt 0pt;"><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">Title of each class</b></p></td><td style="vertical-align:top;width:22.29%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:5pt 0pt 5pt 0pt;"><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">Trading Symbol(s)</b></p></td><td style="vertical-align:top;width:44.35%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:5pt 0pt 5pt 0pt;"><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">Name of each exchange on which registered</b></p></td></tr><tr><td style="vertical-align:top;width:33.34%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:5pt 0pt 5pt 0pt;"><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" name="dei:Security12bTitle" id="Tc_aejdnAODRUaCiH-E7qKKfg_2_0"><span style="font-size:9pt;">Common Stock, $0.001 par value</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:22.29%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:5pt 0pt 5pt 0pt;"><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" name="dei:TradingSymbol" id="Tc_MLlz3Zbtfk-SzDoA9flkPw_2_1"><span style="font-size:9pt;">GLYC</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:44.35%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:5pt 0pt 5pt 0pt;"><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_HtG_BV0hQkSo40U8nFWrUg_2_2"><span style="font-size:9pt;">The Nasdaq Stock Market</span></ix:nonNumeric></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">Ind&#237;cate by check mark whether the registrant is an emerging growth Company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;padding-left:14.25pt;text-indent:-14.25pt;margin:0pt;"><span style="font-size:9pt;letter-spacing:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;">Emerging Growth Company </span><ix:nonNumeric contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_i7EkfcLQhkef6DAoPtirlg"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><div style="margin-left:0pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:97.58%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"> <span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:22.3%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:44.35%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:22.3%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:44.35%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;border-bottom:9pt double #000000;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Courier New';line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_9b3fb018_c176_4020_af5a_398b335adc8d"></a></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:81.18%;border:0;margin:30pt 9.41% 30pt 9.41%;"></div><div style="max-width:100%;padding-left:10.29%;padding-right:10.29%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="color:#000000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;white-space:pre-wrap;">Item 5.02  </b></span><b style="font-weight:bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;">On February 19, 2021, Helen Thackray, M.D., FAAP, Senior Vice President, Clinical Development and Chief Medical Officer of GlycoMimetics, Inc., or the Company, notified the Board of Directors of the Company that she is resigning from her position as Senior Vice President and Chief Medical Officer in order to pursue other business opportunities.  Dr. Thackray&#8217;s employment with the Company will cease as of March 19, 2021.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="color:#000000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">Item 7.01</b></span><b style="font-weight:bold;">Regulation FD Disclosure.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;">On February 23, 2021, the Company issued a press release announcing Dr. Thackray&#8217;s departure from the Company, together with the announcement that Eric J. Feldman, M.D., the Company&#8217;s Vice President, Clinical Development, has been promoted to Senior Vice President and Chief Medical Officer of the Company.  A copy of this press release is furnished herewith as Exhibit 99.1 to this Current Report. The information contained in the press release furnished as Exhibit 99.1 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and is not incorporated by reference into any of the Company&#8217;s filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in any such filing. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Item 9.01 &#160;Financial Statements and Exhibits. </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">(d)&#160;Exhibits</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:7.61%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;width:90.74%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr style="height:1pt;"><td style="vertical-align:bottom;width:7.61%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"></td><td style="vertical-align:top;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:90.74%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"></td></tr><tr><td style="vertical-align:bottom;width:7.61%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.37;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">Exhibit</b></p></td><td style="vertical-align:top;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:90.74%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"></td></tr><tr><td style="vertical-align:bottom;width:7.61%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.37;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">Number</b></p></td><td style="vertical-align:top;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:90.74%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.37;margin:0pt 0pt 0pt 180pt;"><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">Exhibit&#160;Description</b></p></td></tr><tr><td style="vertical-align:top;width:7.61%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;text-align:center;text-indent:-7.2pt;margin:5pt 0pt 5pt 0pt;">99.1</p></td><td style="vertical-align:top;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:90.74%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:5pt 0pt 5pt 0pt;"><a style="-sec-extract:exhibit;" href="glyc-20210219xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.37;text-align:left;">Press Release, dated February 23, 2021, &#8220;GlycoMimetics Promotes Dr. Eric Feldman to Chief Medical Officer.&#8221;</span></a></p></td></tr><tr><td style="vertical-align:top;width:7.61%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;text-align:center;text-indent:-7.2pt;margin:5pt 0pt 0pt 0pt;">104</p></td><td style="vertical-align:top;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:90.74%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:5pt 0pt 0pt 0pt;">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.41%;border:0;margin:30pt 10.29% 30pt 10.29%;"></div><div style="max-width:100%;padding-left:10.29%;padding-right:10.29%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0.05pt;margin:0pt;"><span style="font-size:0.05pt;visibility:hidden;">&#8203;</span></p><a id="_46a103c6_3a69_4f46_8ee0_a528443059fa"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;letter-spacing:-0.1pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:0pt;">SIGNATURES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;text-align:justify;text-indent:37.05pt;margin:0pt;"><span style="letter-spacing:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0.7pt;padding-right:0.7pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:29.85%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:1pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></div></div></td><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:29.85%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">GLYCOMIMETICS, INC.</p></td></tr><tr><td style="vertical-align:top;width:29.85%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:29.85%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">By:&#160;&#160;</p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Rachel K. King</p></td></tr><tr><td style="vertical-align:top;width:29.85%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="white-space:pre-wrap;">Date:  February 23, 2021</span></p></td><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Rachel K. King<br />Chief Executive Officer </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.29%;margin-right:10.29%;margin-top:30pt;page-break-after:avoid;width:79.41%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>glyc-20210219xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.9.1.77--><!--Created on: 2/23/2021 09:30:15 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="clear:both;"></div><div style="clear:left;float:left;height:18.6pt;width:0pt;"></div><div style="clear:left;float:left;height:48pt;margin-right:9pt;width:198.6pt;z-index:251658240;"><div style="height:47.4pt;left:0pt;padding-bottom:0.6pt;position:relative;top:0pt;width:198.6pt;"><img src="glyc-20210219xex99d1001.jpg" alt="A picture containing text  Description automatically generated" style="height:47.4pt;width:198.6pt;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 5pt 0pt;"><b style="font-size:12pt;font-weight:bold;">Exhibit 99.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-left:0pt;margin-right:0pt;margin-top:0pt;"></p><p style="clear:both;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0pt;padding-bottom:5pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:11.25pt;text-align:center;margin:0pt;"><font style="color:#555555;font-weight:bold;letter-spacing:0.9pt;visibility:hidden;">&#8203;</font></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="color:#333333;font-weight:bold;">GLYCOMIMETICS PROMOTES DR. ERIC FELDMAN TO</b></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="color:#333333;font-weight:bold;">CHIEF MEDICAL OFFICER</b></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="color:#555555;font-weight:bold;letter-spacing:0.9pt;text-transform:uppercase;visibility:hidden;">&#8203;</font></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="color:#555555;font-weight:bold;letter-spacing:0.9pt;text-transform:uppercase;visibility:hidden;">&#8203;</font></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Rockville, MD &#8212; February 23, 2021</b> &#8212; GlycoMimetics, Inc.&#160;(Nasdaq: GLYC) today announced the promotion of Eric Feldman, M.D., to Senior Vice President and Chief Medical Officer. Dr. Feldman joined the Company in 2019 and was previously Vice President, Global Clinical Development.</p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#8220;Eric <font style="color:#333333;">is internationally recognized for his work in the development of new therapies for the treatment of leukemias and related bone marrow disorders, and in the past two years, has established himself as a leader in our management group as well as in the trenches with our clinical operations team. Having spent his career dedicated to patients with hematologic malignancies, he is especially well positioned to lead our uproleselan program as it advances through Phase 3 clinical trials. In addition, his extensive clinical research background will serve us well as we drive forward other programs in our pipeline,&#8221; said Rachel King, Chief Executive Officer. </font></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="color:#333333;">Before joining GlycoMimetics, Dr. Feldman served as Chief Medical Officer at Amphivena Therapeutics, Inc., focusing on breakthrough blood cancer treatments and T-cell engagement technologies, and prior to that, he oversaw the myeloid leukemia antibody-drug conjugate (ADC) program at Seattle Genetics, Inc. He has led or participated in the conduct of numerous clinical trials, several leading to U.S. Food and Drug Administration (FDA) approval. Dr. Feldman&#8217;s extensive academic career includes a recent position as Professor of Medicine and Director of the Hematological Malignancies Service at Weill-Cornell/New York Presbyterian Hospital, as well as faculty positions at New York Medical College and the University of Texas, MD Anderson Cancer Center. Dr. Feldman has authored over 150 scientific articles and is a former Editor-in Chief of the journal </font><i style="color:#333333;font-style:italic;">Leukemia Research</i><font style="color:#333333;">. He earned his medical degree at New York Medical College and holds a B.A. from Tulane University.</font></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="color:#333333;visibility:hidden;">&#8203;</font></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="color:#333333;">Separately, Dr. Helen Thackray, M.D. F.A.A.P, has decided to leave the company to pursue another opportunity. She joined the company 15 years ago, and most recently served as Senior Vice President, Clinical Development and Chief Medical Officer.</font></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="color:#333333;visibility:hidden;">&#8203;</font></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="color:#333333;">&#8220;Helen&#8217;s contributions to the Company have been invaluable, leading two programs to late-stage development, and creating important relationships with clinicians all over the world. We are grateful for her years of service to GlycoMimetics and wish her well in her next endeavor,&#8221; said Ms. King.</font></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;"><b style="font-weight:bold;">About Uproleselan (GMI-1271)</b></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Discovered and developed by&#160;GlycoMimetics, uproleselan is an investigational, first-in-class, targeted inhibitor of E-selectin. Uproleselan (yoo&#8217; pro le&#8217; sel an), currently in a comprehensive Phase 3 development program in AML, has received Breakthrough Therapy designation from the&#160;U.S.&#160;FDA and from the Chinese regulatory authority for the treatment of adult AML patients with relapsed or refractory disease. Uproleselan is designed to block E-selectin (an adhesion molecule on cells in the bone marrow) from binding with blood cancer cells as a targeted approach to disrupting well-established mechanisms of leukemic cell resistance within the bone marrow microenvironment. In a Phase 1/2 clinical trial, uproleselan was evaluated in both newly diagnosed elderly and relapsed or refractory patients with AML. In both populations, patients treated with uproleselan together with standard chemotherapy achieved better-than-expected remission rates and overall survival compared to historical controls, which have been derived from results from third-party clinical trials evaluating standard chemotherapy, as well as lower-than-</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;">expected induction-related mortality rates. Treatment in these patient populations was generally well-tolerated, with fewer than expected adverse effects.</p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;"><b style="font-weight:bold;">About&#160;GlycoMimetics, Inc.</b></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;">GlycoMimetics&#160;is a biotechnology company with a focus in hematology-oncology and a pipeline of novel glycomimetic drugs, all designed to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role.&#160;GlycoMimetics&#39;&#160; drug candidate, uproleselan, an E-selectin antagonist, was evaluated in a Phase 1/2 clinical trial as a potential treatment for AML and is being evaluated across a range of patient populations including in a Company-sponsored Phase 3 trial in relapsed/refractory AML under Breakthrough Therapy Designation. Rivipansel, a pan-selectin antagonist, is being explored for use in treatment of acute VOC in sickle cell disease.&#160;GlycoMimetics&#160;has also completed a Phase 1 clinical trial with another wholly-owned drug candidate, GMI-1359, a combined CXCR4 and E-selectin antagonist.&#160;GlycoMimetics&#160;is located in&#160;Rockville, MD&#160;in the&#160;BioHealth Capital Region. Learn more at&#160;www.glycomimetics.com.</p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;"><b style="font-weight:bold;">Forward-Looking Statements</b></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;">This press release contains forward-looking statements. These forward-looking statements include those relating to the potential benefits and impact of the Company&#8217;s drug candidates. Actual results may differ materially from those described in these forward-looking statements. For a further description of the risks associated with these statements, as well as other risks facing&#160;GlycoMimetics, please see the risk factors described in the Company&#8217;s annual report on Form 10-K filed with the&#160;U.S. Securities and Exchange Commission&#160;(SEC) on&#160;February 28, 2020, its quarterly report on Form 10-Q filed with the SEC on November 6, 2020, and other filings&#160;GlycoMimetics&#160;makes with the&#160;SEC&#160;from time to time. Forward-looking statements speak only as of the date of this release, and&#160;GlycoMimetics&#160;undertakes no obligation to update or revise these statements, except as may be required by law.</p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:21pt;margin:0pt;">Investor Contact: <br>Shari Annes<br>Phone: 650-888-0902<br>Email:&#160;sannes@annesassociates.com</p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Media Contact: <br>Jamie Lacey-Moreira<br>Phone: 410-299-3310<br>Email:&#160;jamielacey@presscommpr.com</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>glyc-20210219xex99d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 glyc-20210219xex99d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !? 8X# 2(  A$! Q$!_\0
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MU[M7(=@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>glyc-20210219.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.7713.40453 -->
<!--Based on XBRL 2.1-->
<!--Created on: 2/23/2021 9:30:25 PM-->
<!--Modified on: 2/23/2021 9:30:25 PM-->
<xsd:schema targetNamespace="http://www.glycomimetics.com/20210219" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:attributeFormDefault="unqualified" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:glyc="http://www.glycomimetics.com/20210219">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="glyc-20210219_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="glyc-20210219_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
  <xsd:element name="DocumentAndEntityInformationAbstract" id="glyc_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>glyc-20210219_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.7713.40453 -->
<!--Based on XBRL 2.1-->
<!--Created on: 2/23/2021 9:30:25 PM-->
<!--Modified on: 2/23/2021 9:30:25 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="glyc-20210219.xsd#glyc_DocumentAndEntityInformationAbstract" xlink:label="glyc_DocumentAndEntityInformationAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="glyc_DocumentAndEntityInformationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="glyc_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>glyc-20210219_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.7713.40453 -->
<!--Based on XBRL 2.1-->
<!--Created on: 2/23/2021 9:30:25 PM-->
<!--Modified on: 2/23/2021 9:30:25 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <roleRef xlink:type="simple" xlink:href="glyc-20210219.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="glyc-20210219.xsd#glyc_DocumentAndEntityInformationAbstract" xlink:label="glyc_DocumentAndEntityInformationAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType_637497126259132914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType_637497126259132914" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_637497126259132914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate_637497126259132914" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_637497126259132914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFileNumber_637497126259132914" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_637497126259132914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName_637497126259132914" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_637497126259132914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_637497126259132914" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_637497126259132914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityTaxIdentificationNumber_637497126259132914" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_637497126259132914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressAddressLine1_637497126259132914" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_637497126259132914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressCityOrTown_637497126259132914" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_637497126259132914" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressStateOrProvince_637497126259132914" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_637497126259142915" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressPostalZipCode_637497126259142915" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_637497126259142915" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_CityAreaCode_637497126259142915" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_637497126259142915" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_LocalPhoneNumber_637497126259142915" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_637497126259142915" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_WrittenCommunications_637497126259142915" order="13" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_637497126259142915" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_SolicitingMaterial_637497126259142915" order="14" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_637497126259142915" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_PreCommencementTenderOffer_637497126259142915" order="15" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_637497126259142915" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_637497126259142915" order="16" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_637497126259142915" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_Security12bTitle_637497126259142915" order="17" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_637497126259142915" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_TradingSymbol_637497126259142915" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_637497126259142915" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_SecurityExchangeName_637497126259142915" order="19" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_637497126259142915" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityEmergingGrowthCompany_637497126259142915" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_637497126259152911" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey_637497126259152911" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_637497126259152911" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag_637497126259152911" order="22" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>glyc-20210219x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="glyc-20210219.xsd" xlink:type="simple"/>
    <context id="Duration_2_19_2021_To_2_19_2021_JWL2LJtHS0WjDuQHPj3dKA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001253689</identifier>
        </entity>
        <period>
            <startDate>2021-02-19</startDate>
            <endDate>2021-02-19</endDate>
        </period>
    </context>
    <context id="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001253689</identifier>
        </entity>
        <period>
            <startDate>2020-10-07</startDate>
            <endDate>2020-10-07</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Tc_v3CzH-7TXUCz2qpW6VV_eA_2_1">0001253689</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Tc_owTmJ8QYl0KQeDEf_MZpSg_3_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Narr_O2fhNwlCm02TKG-_Z3oEqQ">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_2_19_2021_To_2_19_2021_JWL2LJtHS0WjDuQHPj3dKA"
      id="Narr_G8MMoVw3P0SQGDmUDTCtZw">2021-02-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Narr_K8Y4vfFOZUa6tggmiN6Kcw">GlycoMimetics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Tc_ljzyWs_qQEK_imUTDSwU1Q_1_0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Tc_q2NpS5wpQkS98fPEVzGtzA_1_2">001-36177</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Tc_weuuiY1AAUiot3H7ieGi4g_1_4">06-1686563</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Narr_PvFooujLY02ONIoqtwGnaw">9708 Medical Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Narr_VYSaZt2q9UmoFUfDLyRUGA">Rockville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Narr_wDIkgHNEZkC_FJpEaofRfg">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Narr_0HfjVvSGeE2nkMsuQWtU8g">20850</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Narr_K_fp6oeFY02JYDsRzVd5yw">240</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Narr_i1lVk4vFIEa_WPOHiGFUVw">243-1201</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Narr_Cf69zpq-uE2G8pmzhiJuoQ">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Narr_X0A8DDt4GkqAdemOH9cptA">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Narr_xDTDxYtXJE67sM0vLKObnw">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Narr_YYZ-3Aj5ikq14B-qi3H97A">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Tc_aejdnAODRUaCiH-E7qKKfg_2_0">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Tc_MLlz3Zbtfk-SzDoA9flkPw_2_1">GLYC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Tc_HtG_BV0hQkSo40U8nFWrUg_2_2">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA"
      id="Narr_i7EkfcLQhkef6DAoPtirlg">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140383770856392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 19, 2021</div></th>
<th class="th"><div>Oct. 07, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_glyc_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 19,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">001-36177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">GlycoMimetics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">06-1686563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9708 Medical Center Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Rockville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">243-1201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">GLYC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0001253689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_glyc_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">glyc_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>glyc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M;%!+ 0(4 Q0    ( -.#5U*2(H%?[@   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( -.#5U*97)PC$ 8  )PG
M   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ TX-74@V  +-3!   T!   !@              ("!#0@  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( -.#5U*#J:4#U $  #(&
M   -              "  98,  !X;"]S='EL97,N>&UL4$L! A0#%     @
MTX-74I>*NQS     $P(   L              ( !E0X  %]R96QS+RYR96QS
M4$L! A0#%     @ TX-74APX9>H_ 0  / (   \              ( !?@\
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( -.#5U(D'INBK0   /@!   :
M              "  >H0  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( -.#5U)ED'F2&0$  ,\#   3              "  <\1  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  !D3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="glyc-20210219x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="glyc-20210219x8k.htm">glyc-20210219x8k.htm</File>
    <File>glyc-20210219.xsd</File>
    <File>glyc-20210219_lab.xml</File>
    <File>glyc-20210219_pre.xml</File>
    <File>glyc-20210219xex99d1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "glyc-20210219x8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 2,
   "dts": {
    "inline": {
     "local": [
      "glyc-20210219x8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "glyc-20210219_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "glyc-20210219_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "glyc-20210219.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "glyc",
   "nsuri": "http://www.glycomimetics.com/20210219",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "glyc-20210219x8k.htm",
      "contextRef": "Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00090 - Document - Document and Entity Information",
     "role": "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "glyc-20210219x8k.htm",
      "contextRef": "Duration_10_7_2020_To_10_7_2020_8ow3pvmQlU6fekRjTxsmnA",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "glyc_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.glycomimetics.com/20210219",
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001558370-21-001475-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-21-001475-xbrl.zip
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MW2:8EC4WZ.Y./N#)+WM I5W"*Y=E,1?RJ1?79$*C!!/W+'M8_M"$(=Q'YV2
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M@*X]D,<-PCV9BY);FD:!NRI(=[WA*$R8UA%<,/O4L8!H#<:K)'3^L]AC%R@
MYG8E469B\-]6^Y2RIX<O5V JA1J<T>LB>6P+QT%2)D7Z8>,G33[ [V+@2Q:P
MT C8!91L(*8\!;JN91.#?Y9W>: "&!O(GW!6'847BG.&3W?8HW&/!T)&0U2R
MX Y7+;25"3,^3@ODT89H]!) MFO63>YTG31XN%W6G[T/,HH1SR%/'*_N88.
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M     &=L>6,M,C R,3 R,3DN>'-D4$L! A0#%     @ TX-74F'ZK:6/!0
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K8RTR,#(Q,#(Q.7AE>#DY9#$N:'1M4$L%!@     %  4 30$  #@T      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
